Bucks County pharmaceutical company to expand and create new jobs

(WPHL) — Apozeal Pharmaceuticals Inc., based in Levittown, will be investing $4.1 million into expanding its drug manufacturing operation in Bucks County, Governor Josh Shapiro announced.

In addition, with support from a $1.1 million state investment, 70 new jobs will be created over the next three years, while retaining 22 existing positions.

The Pennsylvania company owns 11 FDA-approved generic versions of brand-name drugs (Abbreviated New Drug Application/ANDA) along with other over-the-counter (OTC) products. Currently, Apozeal produces four of the 11 products. According to the Shapiro Administration, the expansion will enable the company to manufacture the remaining seven ANDA products and additional OTC products.

“Pennsylvania is a leader in biotech and life sciences with a talented workforce, access to key markets, and significant laboratory infrastructure,” said Governor Shapiro. “Apozeal’s continued growth in our Commonwealth strengthens this legacy while creating more opportunity for Pennsylvanians. My Administration is committed to supporting the life sciences industry and the thousands of Pennsylvanians working in this doing critical, life-saving work industry.”

Apozeal Pharmaceuticals Inc.’s mission is to produce 100% of its products in the United States, and in order to do so, the company acquired the Levittown facility from Torrent Pharmaceuticals Inc. in 2023. Through a series of acquisitions, the company was first founded by pharmacists in 1992 as Biopharm Inc.